Abstract
We assessed the quality of life (QOL) at least one year after sequential chemoradiotherapy for the treatment of localized gastric diffuse large B-cell lymphoma (DLBCL). We used the EORTC Quality of Life Questionnaire for Stomach Cancer (EORTC QLQ-STO22). Among the 45 patients available at the one-year follow-up after radiation therapy, 40 patients completed the EORTC QLQ-STO22 questionnaire. Their median age was 54.5 (range, 20–70 years). Social functioning was most adversely affected among the respondents with a score of 59, whereas other functions and the global scales were preserved above a score of 70 by linearly transformed values. Fatigue, the financial impact and specific emotional problems such as “thinking about their illness” (STO-ANX) and “worry about weight loss or future health” (STO-BI) were persistently bothersome for some patients. Other stomach-related symptoms such as dysphagia, pain, or reflux were negligible at 1 year after treatment. Therefore, this organ-preserving combined approach was effective for the maintenance of the QOL and minimization of stomach abnormalities in patients with gastric lymphoma.
Similar content being viewed by others
References
Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Br J Cancer. 1999;79:1929–34.
Ko YH, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer. 1998;83:806–12.
Amer MH, El-Akkad S. Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology. 1994;106:846–58.
Koch P, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19:3861–73.
Binn M, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol. 2003;14:1751–7.
Liu HT, et al. Chemotherapy alone versus surgery followed by chemotherapy for stage I/IIE large-cell lymphoma of the stomach. Am J Hematol. 2000;64:175–9.
Raderer M, et al. Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE. Cancer. 2000;88:1979–85.
Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. Semin Oncol. 1999;26:324–37.
Blazeby JM, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer. 2004;40:2260–8.
Park YH, et al. CHOP followed by involved field radiotherapy for localized primary gastric diffuse large B-cell lymphoma: Results of a multi center phase II study and quality of life evaluation. Leuk Lymphoma. 2006;47:1253–9.
Vickery CW, Blazeby JM, Conroy T, Johnson CD, Alderson D. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer. Br J Surg. 2000;87:362–73.
Fayers PM, et al. (ed). EORTC QLQ-C30 scoring manual, 3rd edn. Brussels: EORTC Quality of Life Group; 2001, p. 6–14. http://www.eortc.be/home/qol/manuals.htm. Accessed March 2008.
The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329:987–94.
Homepage of EORTC Qulaity of Life Group. http://groups.eortc.be/qol/questionnaires_qlqc30.htm. Accessed March 2008.
Acknowledgment
We acknowledge the EORTC to permit using the EORTC-STO22 module to conduct QOL analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
Won Seog Kim and Yeon Hee Park have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Kim, W.S., Park, Y.H., Lee, SH. et al. Quality of life one year after chemoradiotherapy for localized primary gastric diffuse large B-cell lymphoma. Med Oncol 25, 447–450 (2008). https://doi.org/10.1007/s12032-008-9065-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-008-9065-z